Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients
Recruiting
Phase 4
Interventional Study
Neuromuscular Blockade
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 80 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 80 (estimated)
- Sponsor
- Matias Vested · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this study is to determine the onset time of rocuronium after administration of ephedrine 0.15 mg/kg in patients with age ≥ 80 years. The hypothesis of this study is that ephedrine 0.15 mg/kg provides a shorter onset time compared to placebo (saline).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 80
* Scheduled for elective operations under general anesthesia with intubation
* American Society of Anesthesiologists physical status classification (ASA) I to III
* Informed consent
* Read and understand Danish
Exclusion Criteria:
* Known allergy to rocuronium or ep…
Contacts